SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-030708
Filing Date
2024-07-02
Accepted
2024-07-02 07:04:27
Documents
14
Period of Report
2024-07-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ardx-20240702.htm   iXBRL 8-K 26089
5 ardx-20240702_g1.jpg GRAPHIC 2570
  Complete submission text file 0001628280-24-030708.txt   159289

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20240702.xsd EX-101.SCH 1901
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20240702_lab.xml EX-101.LAB 22548
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20240702_pre.xml EX-101.PRE 13046
16 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20240702_htm.xml XML 2894
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 241092875
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)